Nov 3 (Reuters) - ADDEX THERAPEUTICS LTD ADXN.S :
* Q3 NET LOSS -3.3 MILLION CHF
* Q3 DILUTED EPS LOSS 0.12 CHF VERSUS 0.14 CHF LOSS YEAR AGO
* INCOME DECREASED BY CHF 0.4 MILLION TO CHF 0.1 MILLION IN
Q3
2020, COMPARED TO CHF 0.5 MILLION IN Q3 2019
* RESEARCH AND DEVELOPMENT COSTS DECREASED BY CHF 0.9
MILLION TO
CHF 2.0 MILLION IN Q3 2020 COMPARED TO Q3 2019
* NET LOSS DECREASED BY CHF 0.3 MILLION TO CHF 3.3 MILLION
IN Q3
2020 COMPARED TO Q3 2019 AND CHF 0.4 MILLION TO CHF 10.8 MILLION
FOR NINE-MONTH PERIOD ENDED SEPTEMBER 30, 2020
Source text for Eikon: ID:nGNE4c3J0M
Further company coverage: ADXN.S
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))